Figs Inc. (NYSE:FIGS) is renowned for its innovative approach to healthcare apparel, specializing in designing and selling scrubs that prioritize comfort and style. Operating within the Zacks Retail - Apparel and Shoes industry, Figs has successfully established a niche by delivering high-quality products that resonate with healthcare professionals.
On August 8, 2025, Telsey Advisory updated its rating for FIGS to "Market Perform," maintaining its previous stance. The firm advises holding the stock, noting its price at $6.22 at the time of the announcement. Additionally, Telsey Advisory has uplifted its price target for FIGS from $5 to $7, as reported by TheFly, indicating a positive outlook for the stock despite existing challenges.
Figs reported impressive second-quarter earnings, with a profit of $0.04 per share, doubling the Zacks Consensus Estimate of $0.02 per share. This performance marks a significant improvement from the $0.01 per share earnings recorded in the same quarter last year. The earnings surprise for this quarter was a remarkable 100%, showcasing the company's ability to exceed expectations.
In terms of revenue, Figs generated $152.64 million for the quarter ending June 2025, surpassing the Zacks Consensus Estimate by 5.25%. This represents an increase from the $144.23 million in revenue reported in the same period last year. The company has outperformed consensus revenue estimates in three of the last four quarters, indicating a strong sales performance.
Despite these positive financial results, the current stock price of FIGS is $6.20, reflecting a decrease of approximately 5.42% with a change of $0.36. Today, the stock has traded as low as $6.07 and as high as $7.00. Over the past year, FIGS has reached a high of $7.06 and a low of $3.57. The company has a market capitalization of approximately $1.01 billion, with a trading volume of 1,612,069 shares on the NYSE.
